Results 131 to 140 of about 300,077 (226)

Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b. [PDF]

open access: yesTher Adv Hematol
Yoon SY   +14 more
europepmc   +1 more source

A reappraisal of the benefit‐risk profile of hydroxyurea in polycythemia vera: A propensity‐matched study

open access: yesAmerican journal of hematology/oncology, 2017
T. Barbui   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy